Display of disulfide linked dimeric proteins in filamentous phage

• US 8,728,985 B2
• Filed: 11/15/2010
• Issued: 05/20/2014
• Est. Priority Date: 11/17/2009
• Status: Expired due to Fees

• Current Assignee: Centocor Ortho Biotech Incorporated (Johnson & Johnson)
• Original Assignee: Centocor Ortho Biotech Incorporated (Johnson & Johnson)
• Inventors: Huang, Chichi, Spinka-Doms, Tracy, Fransson, Johan
• Primary Examiner(s): BOESEN, CHRISTIAN C
• Application Number:
  US13/509,292
• Publication Number:
  US 20120225085A1
• Time in Patent Office: 1,282 Days
• Field of Search: None
• US Class Current: 506/18
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: C12N 15/1037 Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
• CPC Class Codes: C12N 15/70 Vectors or expression systems specially adapted for E. coli

Abstract

Methods are provided for the display of a complex homodimer protein on the surface of a bacteriophage particle and combinatorial synthetic libraries of such proteins displayed as a fusion polypeptide with filamentous phage pIX coat protein. Heterodimeric or more complex interchain bonded structure, such as disulfide-linked, multimeric proteins, may be displayed using the method of the invention.

Claims

1. A replicable phage vector for the display of a functional, multimeric, interchain disulfide linked protein on the surface of a filamentous phage particle;

comprising nucleic acid sequences encoding an inducible promoter and nucleic acid sequences encoding a first polypeptide chain and a second polypeptide chain wherein each chain consists of amino acid residues according to the following formula;

N-(a bacterial secretion signal)-(Formula I)-(a phage coat protein)-C

wherein N is the N-terminus and C is the C-terminus;

wherein the phage coat protein is a phage pIX or pVII protein;

wherein Formula I is V1_o-Pep_a-Flex_n-V2_m-Hinge-CH₂—

CH₃;

wherein Pep represents a bioactive peptide or polypeptide capable of specifically recognizing a target;

wherein Flex is an optional flexible linker polypeptide that provides structural flexibility;

wherein V1 and V2 are bracketing sequences;

wherein Hinge is at least a portion of an immunoglobulin hinge region selected from the group consisting of;

SEQ ID NO;

1-4, SEQ ID NO 1 amino acid residues 11-15, SEQ ID NO 2 amino acid residues 8-12, SEQ ID NO 3 amino acid residues 13-61 and SEQ ID NO 4 amino acid residues 8-12;

wherein CH₂ is at least a portion of an immunoglobulin CH₂ constant region;

wherein CH₃ is at least a portion of an immunoglobulin CH₃ constant region;

wherein m, n and o can be zero or can be an integer between 1 and 10, and a can be an integer from 1 to 10;

wherein said encoded Hinge amino acid sequence comprises at least one cysteine residue;

wherein a cysteine residue on the first polypeptide chain is capable of becoming oxidatively bonded to a Hinge cysteine residue on the second polypeptide chain; and

whereby the cysteine bond so formed is an interchain disulfide of the functional multimeric structure being displayed on the surface of the same filamentous phage particle.

2. The phage vector of claim 1 wherein functional activity of the protein structure is selected from protein A binding and FcRn binding.

3. The phage vector of claim 1, wherein the interchain disulfide lies within the amino acid sequence of the antibody hinge domain.

4. The phage vector of claim 3 wherein the CH₂ constant region is selected from the group consisting of SEQ ID NOs:

5, 6, 7, and 8 and the CH₃ constant region is selected from the group consisting of SEQ ID NOs;

9, 10, 11, and 12.

5. The phage vector of claim 1, wherein the bacterial secretion signal is selected from the group consisting of wild-type pelB sequence SEQ ID NO:

14, wild-type ompA and SEQ ID NO;

15.

6. The phage vector of claim 1, wherein the inducible promoter is a lac promoter or mutant of lac.

7. A phage library of bacterial host cells comprising a nucleic acid phage vector according to claim 3 wherein specific positions within the vector comprises sequences that vary one from another at specific residues.

8. The phage vector of claim 1, wherein the V1 and V2 bracketing sequences are derived from an antibody variable (V) domain Vh framework.

9. The phage vector of claim 8, wherein the V1 is the sequence QIQ and the V2 represents a sequence derived from an immunoglobulin J gene domain and is GTLVTVSS (SEQ ID NO:

13).